Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Blood

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Blood|November 13, 2025
Guardians of the tumor microenvironment: the neutrophil sagaSamir Parekh
Blood|March 3, 2012
Taking it up a notch in MCLSamir Parekh
Blood|November 18, 2021
(Distinct) origins of IgM myelomaAlessandro Laganà, Samir Parekh
Blood|November 7, 2007
Lenalidomide-induced severe hepatotoxicitySubuhee Hussain, Royston Browne, Julie Chen, et al.
Blood|August 28, 2009
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeBritta Will, Masahiro Kawahara, Julia P Luciano, et al.
Blood|June 5, 2007
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanismsSamir Parekh, Jose M Polo, Rita Shaknovich, et al.
Blood|July 21, 2011
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCLMatko Kalac, Luigi Scotto, Enrica Marchi, et al.
Blood|April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor developmentPei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Blood|October 15, 2016
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCLYun Mai, J Jessica Yu, Boris Bartholdy, et al.
Blood|May 12, 2026
Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathwaysHsiling Chiu, Junfei Zhao, Tara Basavanhally, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Blood|November 13, 2025
Guardians of the tumor microenvironment: the neutrophil sagaSamir Parekh
Blood|March 3, 2012
Taking it up a notch in MCLSamir Parekh
Blood|November 18, 2021
(Distinct) origins of IgM myelomaAlessandro Laganà, Samir Parekh
Blood|November 7, 2007
Lenalidomide-induced severe hepatotoxicitySubuhee Hussain, Royston Browne, Julie Chen, et al.
Blood|August 28, 2009
Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndromeBritta Will, Masahiro Kawahara, Julia P Luciano, et al.
Blood|June 5, 2007
BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanismsSamir Parekh, Jose M Polo, Rita Shaknovich, et al.
Blood|July 21, 2011
HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCLMatko Kalac, Luigi Scotto, Enrica Marchi, et al.
Blood|April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor developmentPei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Blood|October 15, 2016
An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCLYun Mai, J Jessica Yu, Boris Bartholdy, et al.
Blood|May 12, 2026
Mezigdomide reverses T-cell exhaustion through degradation of IKZF1/IKZF3 and reinvigoration of cytokine production pathwaysHsiling Chiu, Junfei Zhao, Tara Basavanhally, et al.
Pageof 2